BioCentury
ARTICLE | Product Development

Asthma roadMAP

July 3, 2006 7:00 AM UTC

deCode genetics Inc. says population genetics work showing that MAP kinase is an important factor in asthma enabled the company to repurpose a failed Parkinson's disease product from Cephalon Inc. DCGN reported positive data on the compound last week.

"We isolated the genetic variants that confer risk of developing asthma, and it turns out that the gene makes MAP kinase," said Kari Stefansson, president and CEO of DCGN (Reykjavik, Iceland)...